✦ LIBER ✦

Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial

✍ Scribed by Ritesh Patil; Guy T. Clifton; Jarrod P. Holmes; Asna Amin; Mark G. Carmichael; Jeremy D. Gates; Linda H. Benavides; Matthew T. Hueman; Sathibalan Ponniah; George E. Peoples

Book ID: 113679647
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 728 KB
Volume: 210
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2009.10.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunological monitoring of regulatory T

Immunological monitoring of regulatory T cells by flow cytometry in a novel HLA Class II HER2/neu peptide vaccine clinical trial in breast cancer patients

✍ Matthew T. Hueman; Steven Khoo; Catherine Storrer; Katie Harris; Yusuf Jama; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Immunological monitoring of in vitro and

Immunological monitoring of in vitro and in vivo immune responses to the Ii-Key/HER2/neu MHC class II peptide vaccine in a phase I clinical trial in breast cancer patients

✍ S. Khoo; C.E. Storrer; K.A. Harris; Y.H. Jama; Z.A. Dehqanzada; C.D. Shriver; E. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Early results of a phase I clinical tria

Early results of a phase I clinical trial of an Ii-Key/HER2/neu MHC Class II peptide-based vaccine in breast cancer patients

✍ Steven Khoo; Catherine Storrer; Katie Harris; Yusuf Jama; Anna Smith; Zia Dehqan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparison of immunological responses in

Comparison of immunological responses in node-positive and node-negative breast cancer patients receiving a HER2/neu E75 peptide vaccine

✍ M. T. Hueman; J. M. Gurney; C. E. Storrer; L. Kotula; K. Jackson; M. Wilson; C. 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 296 KB

A more sensitive immunological monitorin

A more sensitive immunological monitoring tool for cancer vaccine trials: A direct comparison of HLA-A2 dimer and tetramer molecules in measuring the in vivo immune response to a HER2/neu peptide-based vaccine (E75) in prostate and breast cancer patients

✍ Matthew T. Hueman; Jennifer Gurney; Michael Woll; Catherine Storrer; David McLeo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Clinical trial results of the HER-2/neu

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients : From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

✍ Elizabeth A. Mittendorf; Guy T. Clifton; Jarrod P. Holmes; Kevin S. Clive; Rites 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1016 KB